Chinese consumers, once the engine of growth for multinational companies, are cutting back on all kinds of things. Designer ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize ...

Shares of Merck & Co. Inc. fell more than 0.5% on Monday afternoon, tracking their fifth consecutive decline in the worst ...

Gardasil vaccine protects against cancer-causing human papilloma virus or HPV infections. The pause announcement comes a month after Merck received approval in China for use of the vaccine in males.

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look at where Merck & Co., Inc.

We’ll have to see if Merck will be able to replace the revenue from its HPV vaccine Gardasil and cancer drug Keytruda (with Keytruda set for patent expiry in two years and Gardasil reporting ...

We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks that ...

Since the prior Gardasil 4 vaccine was introduced ... nearly 400 million have some form of vaccination against HPV, Merck said. And the vaccine can be lifesaving, said Lind, of Dana-Farber.

Merck MRK-N said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak discretionary spending, a move that dented its full-year forecast ...